Piper Sandler Upgrades Moderna (MRNA) to Overweight
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $167.96 -4.99%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 33 | New: 7
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 33 | New: 7
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff upgraded Moderna (NASDAQ: MRNA) from Neutral to Overweight with a price target of $445.00.
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $331.88 yesterday.
You May Also Be Interested In
- Moderna's Covid Vaccine for Omicron and the Original Strain Approved in the UK
- Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK
- UPDATE: Wolfe Research Starts ironSource Ltd. (IS) at Peerperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
